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The aims of this paper were to provide an overview of available activity monitors used in research in patients with heart failure and to
identify the key criteria in the selection of the most appropriate activity monitor for collecting, reporting, and analysing physical activity in
heart failure research. This study was conducted in three parts. First, the literature was systematically reviewed to identify physical activity
concepts and activity monitors used in heart failure research. Second, an additional scoping literature search for validation of these activity
monitors was conducted. Third, the most appropriate criteria in the selection of activity monitors were identified. Nine activity monitors
were evaluated in terms of size, weight, placement, costs, data storage, water resistance, outcomes and validation, and cut-off points for
physical activity intensity levels were discussed. The choice of a monitor should depend on the research aims, study population and design
regarding physical activity. If the aim is to motivate patients to be active or set goals, a less rigorously tested tool can be considered. On the
other hand, if the aim is to measure physical activity and its changes over time or following treatment adjustment, it is important to choose a
valid activity monitor with a storage and battery longevity of at least one week. The device should provide raw data and valid cut-off points
should be chosen for analysing physical activity intensity levels. Other considerations in choosing an activity monitor should include data
storage location and ownership and the upfront costs of the device.
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Introduction
Even modest amounts of regular physical activity in patients with
heart failure (HF) are associated with a lower risk of HF-related
hospital admissions and mortality, and other health-related
outcomes.1,2 As a result, there are increasing numbers of inter-
vention studies under way exploring the effects of encouraging
and increasing physical activity in patients with HF on a variety
of primary outcome variables including mortality, morbidity and
quality of life.3 Other studies have focussed on measures of
functional capacity, either subjective such as New York Heart
Association classification, or objective including the 6-min walk
test distance, and peak cardiopulmonary capacity via peak oxygen
uptake measurement. These assessments are limited by being
snapshots of physical function and do not assess long-term physical
activity. Many terms are used to describe outcomes related to
physical function, such as physical activity, daily physical activity,
non-sedentary behaviour and exercise capacity.
Physical activity is defined as bodily movement produced by
skeletal muscles that results in energy expenditure.4 Both subjec-
tive and objective instruments can be used to measure physical
activity. Subjective measures include self-reported questionnaires
or diaries such as the International Physical Activity Questionnaire
(IPAQ) or the Cambridge Physical Activity Index (CPAI), but these
are limited by subjectivity, recall bias, or participant burden.5–7
Self-reported questionnaires can overestimate physical activity by
up to 44% in men and 138% in women, and also lack the precision
needed to detect changes in physical activity on a day-to-day basis.8
Objective methods to measure physical activity include mea-
sures that directly assess one or more dimensions of physical
activity (e.g. frequency, intensity, time, type), and have the ability
to capture a variety of metrics such as number of steps, minutes of
activity, intensity of activity, and bouts of activity.9 Commonly used
tools include indirect calorimetry and direct observation as well
as wearable devices such as step counters, motor sensors, activity
monitors (a device or application for monitoring and tracking
physical activity). These objective measurements are considered
superior to self-reporting physical activity, as they better capture
the intricacies of physical activity dimensions.10,11 Recently, activity
monitors have been used to provide personalized advice, motivate
and remind patients to be active, and help them to set realistic
goals.12 Hence, activity monitors that are simpler to use have
been proposed as a practical alternative to more formal activity
monitors when no accurate measurement is needed, for example
in clinical practice.13–15
In a more protocolized clinical setting and for research pur-
poses, activity monitors have been considered to quantify and mon-
itor activity counts objectively and continuously over an extended
period of time.16 Activity monitors that sense body accelerations,
commonly known as ‘accelerometers’, capture additional informa-
tion on the intensity, duration and frequency of physical activity,
as well as the number of steps.9 These devices can therefore cap-
ture physical activity intensity levels and provide a more continuous
and comprehensive evaluation of free-living activity.17,18 A relevant
proportion of HF patients have a cardiac device such as a car-



















































































.. resynchronization therapy device, a wearable shock vest, or ven-
tricular assist devices. Some of these cardiac devices can also mea-
sure physical activity in these patients.19,20 Finally, smartphone and
smartwatch-based applications, such as MyHeart Counts, play a
role in measuring physical activity.21,22
Nevertheless, one challenge is that there is no ‘gold standard’
for activity monitoring in research on cardiac patients, leading to a
large variety of equipment used and values reported. Such a variety
of tools, each with limited validation data, hinders the comparability
of results and has delayed the growth of a reliable evidence
base in terms of assessing the effect of training interventions and
other interventions on activity. The challenges outlined above are
exacerbated in patients with HF because of their very low physical
activity levels, frailty and abnormalities of cognition, such that
not all monitors are suitable in all patients. A recently published
review23 assessed the methods used for collecting and processing
accelerometer data in cardiology, but more work is needed to
address the challenges of comprehensive and consistent collecting,
reporting, and analysing of physical activity in patients with HF.
The aims of this paper were to provide an overview of available
activity monitors used in research in patients with HF and to
identify the most appropriate criteria in the selection of the most
adequate activity monitor for collecting, reporting, and analysing
physical activity in HF research.
Methods
This study is conducted in three parts. First, we conducted a systematic
literature review to identify important physical activity concepts and
activity monitors that have been used in research on patients with HF.
Second, we performed an additional scoping review using electronic
resources and the manuals for the available activity monitors to
describe their validation. Third, the most appropriate criteria in the
selection of the most adequate activity monitor were identified from
the current literature, and were shared and discussed among the
members of the Committee on Exercise Physiology and Training of
the Heart Failure Association of the European Society of Cardiology.
Next to the design and aim of research to measure physical activity, the
validity of the measurement, data storage, data access, completeness
and costs were considered important criteria in selection of an activity
monitor in HF research.
The literature search included online electronic databases (PubMed,
Scopus, CINAHL and Web of Science), and was conducted in October
2017 and updated in April 2020. The following search string was
utilized across the databases: (‘accelerometer’ OR ‘accelerometry’
OR ‘motion sensor’ OR ‘activity monitor’) AND (‘heart failure’).
For inclusion in this analysis, studies were required to be published
or in press, peer-reviewed literature and in the English language.
Studies that include patients under 18 years old, studies that were
not explicitly related to physical activity and studies that were not
specifically related to HF were excluded. Additionally, we excluded
studies including pedometers measuring only steps, which are often
inaccurate at slow gait speed.24 Measuring steps only can ignore the
intensity, duration and frequency of physical activity, which we consider
important aspects of measuring physical activity. Two authors (L.K. and
M.K.) independently reviewed the results of each search according the
inclusion and exclusion criteria. A third author (E.L.) adjudicated in
cases of disagreement.
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Table 1 Concepts and definition in activity monitoring
Concept Description
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Activity count Activity that causes an acceleration signal to exceed a threshold is ‘counted’ as activity; anything below this
threshold is ignored. At the end of a measurement period, the number of activity ‘counts’ is recorded.
Activity trackers and monitors Device or application for monitoring and tracking physical activity.
Type (dose) The type and amount of reported or prescribed physical activity.25
Time (duration) The length of time for each session or bout.25
Frequency Sessions or bouts of moderate-to-vigorous physical activity per day or per week.25
Intensity The rate of energy expenditure required to perform any physical activity. It can be measured in METs,
kilocalories, joules, or oxygen consumption.
Energy expenditure The amount of energy that a person needs to carry out physical functions.
Epoch A particular period of time in a person’s life.
Exercise A subset of physical activity that is planned, structured and repetitive and has as a final or an intermediate
objective the improvement or maintenance of physical fitness.4
Light-intensity activity Requires 1.6 to less than 3.0 METs; examples include walking at a slow or leisurely pace (2 mph or less),
cooking activities, or standing while scanning groceries as a cashier.26
Metabolic equivalent of task (MET) The objective measure of the ratio of the rate at which a person expends energy, relative to the mass of
that person, while performing some specific physical activity compared to a reference.
One MET is the rate of energy expenditure while sitting at rest, which, for most people approximates an
oxygen uptake of 3.5 mL/kg/min. The energy expenditure of other activities is expressed in multiples of
METs. For example, for the average adult, sitting and reading requires about 1.3 METs. Strolling or
walking slowly requires about 2.0 METs. Walking at about 3.0 miles/h requires about 3.3 METs, and
running at 5 miles/h requires about 8.3 METs. The average rate of energy expenditure for a substantial
number of activities has been documented for the general adult population.26
Moderate-intensity activity Requires 3.0 to less than 6.0 METs; examples include walking briskly or with purpose (3 to 4 mph),
mopping or vacuuming, or raking a yard.26
Physical activity Any bodily movement produced by skeletal muscles that results in energy expenditure.4
Sedentary behaviour Any waking behavior characterized by an energy expenditure of 1.5 or fewer METs while sitting, reclining,
or lying.27
Uniaxial, biaxial and triaxial Uniaxial activity monitors measure acceleration in one plane, usually vertical to the ground. Biaxial and
triaxial refer to activity monitors which measure acceleration in two or three planes, respectively.
Vigorous-intensity activity Requires 6.0 or greater METs; examples include walking very fast (4.5 to 5 mph), running, carrying heavy
groceries or other loads upstairs, shoveling snow by hand, mowing grass with a hand-push mower, or
participating in an aerobics class.26
Vector magnitude unit The vectorial sum of activity in the three orthogonal directions measured over a 1-min period.
Volume The quantification of the dose of activity accumulated over a specified length of time. In activity monitors,
volume are activity counts or step counts during a set period of time.25
Results
Overall, 45 studies from 489 publications were identified as rele-
vant, and full copies were retrieved and assessed (online supple-
mentary Figure S1 and Table S1).
Concepts related to physical activity
The most frequently used concepts in research on activity mon-
itors were physical activity and exercise (Table 1).4,25–27 Physical
activity is any bodily movement produced by skeletal muscles
that results in energy expenditure. Exercise is a subset of physical
activity, but it is planned, structured and repetitive, and its final
or intermediate objective is the improvement or maintenance
of physical fitness.4 Physical activity or exercise is prescribed by
health care professionals to their patients with HF following the
FITT principle (frequency, intensity, time/duration and type). The


























. day or per week, and the intensity is the rate of energy expendi-
ture (sedentary-light-moderate to vigorous) required to perform
any physical activity.25 ‘Type’ indicates the characteristics and the
amount of prescribed physical activity, while ‘time’ describes the
duration of each session. Most activity monitors measure activity
counts and/or step counts, where activity counts are acceleration
signals that exceed a threshold and are therefore ‘counted’ as
activity.
Activity monitors in heart failure
research
Seventeen activity monitors were described in the retrieved
articles on patients with HF (Table 2).28–43 Of these 17 activity mon-
itors, eight [Actical (Minimitter, Inc., Respironics, Bend, OR, USA),
ActiGraph Model GT1M Model and ActiGraph 7164 (ActiGraph,
Pensacola, FL, USA), ActivPAL™ (PAL Technologies Ltd., Glasgow,
UK), Caltrac (Muscle Dynamics, Torrance, CA, USA), the Chiron
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
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Table 3 Cut-off points for sedentary time, light physical activity, moderate physical activity and vigorous activity in
adults and older adults
Age group Sedentary time Physical activity
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Light Moderate Vigorous
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adults
Freedson et al.44 ≤99 100–759 760-5724 ≥5725
Troiano et al.45 ≤100 101–2019 2020-5998 ≥5998
Older adults
Copeland et al.46 ≤99 100–1039 ≥1040 NA
Davis and Fox47 ≤199 200–1999 2000–3999 ≥4000
Metzger et al.48 ≤149 150–2019 ≥2020 NA
Troiano et al.45 ≤100 101–2019 2020–5997 ≥5998
NA, not available.
wearable sensor platform, SenseWear Pro3 Armband (BodyMedia,
Inc, Pittsburgh, PA, USA) and the Temec activity monitor (Temec
Instruments Kerkrade, The Netherlands)] were not available or
not yet available to purchase on the market and therefore were
not considered. One activity monitor, the HJA-750C Active Style
Pro (OMRON Healthcare Co., Ltd., Kyoto, Japan), despite being
available outside Japan, only provided software and support-
ing information in Japanese. This device was also not considered.
Another activity monitor, the Move II (Movisens, GmbH, Karlsruhe,
Germany), was no longer available, but had been replaced with
the Move 4 (Movisens, GmbH, Karlsruhe, Germany) which has all
the functionality of the Move II, with user-relevant improvements
including better battery longevity and improved water-resistant
casing. Given the availability of information on the Move II, we
considered the potential of the Move 4 for patients with HF.
The remaining monitors (n = 9) were subsequently classified
into three groups: uniaxial, triaxial and multisensory. Table 2
presents data on basic characteristics such as the size, weight,
placement, costs, data storage, water resistance, possibilities to
measure length and quality of sleep, outcomes and validation of
these activity monitors.
Uniaxial activity monitors
Uniaxial monitors measure the degree and intensity of movement
in a vertical plane, by identifying periods of standing and step-
ping activity. Only one activity monitor, the Kenz Lifecorder EX
(Suzuken Co., Ltd., Nagoya, Japan), has been used in HF research
and is still available. This device (dimensions: 7.25× 4.15× 2.75 cm)
is worn on the thigh or over the hip, and measures steps. It is not
water resistant. The memory capacity allows activity and posture
to be recorded continuously for periods of up to 200 days. Data can
be transferred with a USB cable to a personal computer running
Windows 98SE/Millennium/2000 and XP only.
Triaxial activity monitors
Triaxial activity monitors measure multidirectional movement


























































. used in HF research: ActiGraph GT3X, AX3, Fitbit Flex, Stayhealthy
RT3 and TracmorD. Most of these are worn using an elastic belt
or in a clip pouch on the hip or waist. The TracmorD can also be
worn as a necklace or on the lower back. One monitor was sweat,
rain and splash proof (Fitbit Flex), while two were waterproof up
to 1 m (ActiGraph GT3X and Stayhealthy RT3), one up to 1.5 m
(AX3) and one up to 3 m (TracmorD). Most of these are accept-
ably small (ranging from 23× 32.5× 7.6 mm to 71× 56× 28 mm)
and all of them convert accelerations into activity count values,
allowing energy expenditure to be calculated. The sum of activity
counts in an epoch is linearly related to activity intensity and can
be classified into intensities of physical activity based on validated
and established activity count cut points (Table 3).44–48
The monitors differ in terms of memory capacity: the ActiGraph
memory allows activity and posture to be recorded continuously
for periods of up to 19 days, the Actical up to 45 days, the
Stayhealthy RT3 up to 21 days, the Move 4 up to 7 days, the Fitbit
Flex up to 5 days, and the TracmorD up to 22 weeks. With some
activity monitors, software (compatible with a Windows operating
system) is needed to download the data (ActiGraph GT3X, AX3,
Stayhealthy RT3) to a personal computer, while with others (Fitbit
Flex and TracmorD) the data can be uploaded to a website online,
in an online cloud. One activity monitor (ActiGraph) has the option
to buy a data hub, which allows data to be transferred (in encrypted
form) through a Bluetooth connection to an online cloud.
Multisensory activity monitors
The Fitbit Charge HR, the GENEActiv and the Move 4 are multisen-
sory triaxial activity monitors. The Fitbit Charge HR incorporates
a heart rate sensor, the Move 4 has a rotation rate sensor, a
pressure sensor and a temperature sensor, and the GENEActiv
has an ambient light and temperature sensor. These are small
devices (ranging from 43× 40×13 mm to 62.3× 38.6× 11.5 mm)
that can be worn on the wrist, although the Move 4 can also be
worn on the hip or the chest. Two monitors were sweat, rain and
splash proof (Fitbit Charge HR and Move 4), while the GENEActiv
is totally waterproof. The Fitbit Charge has a battery longevity of
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
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5 days, and the GENEActiv and Move 4 have a battery longevity
of 7 days.
For data transfer, two multisensory activity monitors (GENE-
Activ and Move 4) need to be connected via a USB cable to
a personal computer with a software developed for the specific
monitor (applicable for Windows operating systems). One activ-
ity monitor needs to be connected via a USB cable to a per-
sonal computer, where the data can be uploaded to a website
(online cloud).
Validation of the activity monitors
For this report we have divided the validation evidence into that
collected in the field and that collected in the laboratory (Table 2).
Field validation is validation of an activity monitor against indi-
rect calorimetry, using the doubly labelled water technique (the
gold standard). In the doubly labelled water technique, participants
are given a known volume of water which contains ‘marker iso-
topes’. Over a period of days or weeks, samples of body water
(from saliva, urine or blood plasma) are assessed for the elimination
of these isotopes, which occurs through the body’s metabolism.
There is a direct correlation between energy expenditure and
the amount of carbon dioxide and metabolic water produced.
The changes in the isotopes in the body water over time are
linked to oxygen usage and carbon dioxide production, both of
which are major biochemical components of energy metabolism.49
Correlation coefficients between total and active energy expen-
diture measured by the activity monitor and total and active
energy expenditure measured with doubly labelled water were
extracted.
Laboratory validation involves the comparison of data obtained
from the monitor against data from indirect calorimetry during
exercise, using either a metabolic cart, a metabolic chamber
or direct observation. A metabolic cart measures the oxygen
consumed and the carbon dioxide produced by a subject, and then
calculates the energy expenditure. A metabolic chamber measures
the amount of heat (energy) produced by a subject enclosed within
a chamber. With indirect calorimetry, the amount of heat (energy)
produced by a subject is measured by determining the amount of
oxygen consumed and the quantity of carbon dioxide eliminated.
Correlation coefficients between activity monitor outcome and
energy expenditure measured by metabolic cart/chamber were
extracted.
Field validation
We first analysed studies that included validation of the total
energy expenditure activity monitor against the total energy
expenditure measured with doubly labelled water. The total
energy expenditure for the GENEActiv and the Move 4 was not
validated with doubly labelled water. The total energy expenditure
was validated in healthy adults using the Kenz Lifecorder (r = 0.83),
the ActiGraph GT3X (r = 0.80), the AX3 (r = 0.87–0.91), the
Fitbit Flex (r = 0.84), the Stayhealthy RT3 (r = 0.32) and the



















































































.. Second, we analysed studies that included the validation of
the active energy expenditure measured with the activity moni-
tor against the active energy expenditure measured with doubly
labelled water.
The active energy expenditure was validated in healthy adults
using the AX3 (r = 0.59–0.69) and the TracmorD (r = 0.48). The
active energy expenditure was validated in patients with a chronic
disease using the Stayhealthy RT3 (r = 0.67).
Laboratory validation
For the laboratory validation, we looked at the correlations
between the activity monitor outcomes and the total energy
expenditure measures from indirect calorimetry during laboratory
protocols. The Fitbit Charge HR was not validated by laboratory
validation. The laboratory validation was carried out on healthy
adults using the Kenz Lifecorder (r = 0.56–0.96), the ActiGraph
GT3X (r = 0.88), the Fitbit Flex (r = 0.90), the Stayhealthy RT3
(r = 0.48–0.94), the TracmorD (r = 0.89) and the GENEActiv
(r = 0.97). The AX3 was laboratory validated for stroke patients
(r = 0.63–0.87), the Stayhealthy RT3 was validated for healthy and
overweight adults (r = 0.47), and the GENEActiv was validated for
patients with HF.
Discussion
Researchers who either study physical activity in patients with HF
or wish to assess the effects of interventions on physical activity
face the challenge of choosing the most appropriate monitor
for the patient group and the intervention. The difficulties are
compounded because no overview exists of the utility of these
devices regarding practical and scientific issues. With this paper we
have therefore summarized the practical and scientific differences
between activity monitors used for research patients with HF.
Decide on the aims
The choice of a monitor should depend on the research aims
and design regarding physical activity. For non-pharmacological
interventions the aim could be to motivate patients to be active
or set goals. A less rigorously tested tool can be considered (e.g.
activity tracker, smartphone apps50,51). In non-pharmacological and
pharmacological interventions, the aim could also be to measure
physical activity and its changes over time, such that it is important
to choose a valid and reliable activity monitor.
Consider validation
For research purposes, an activity monitor validated with the
gold standard (doubly labelled water) is preferred. Three activity
monitors, the Fitbit Charge HR, the GENEActiv and the Move 4,
were not field validated.
Also, it is important to use validated cut-off points for physical
activity levels in patients with HF. Cut-off point to investigate the
relationship between activity counts and activity intensity level,
should be chosen according to the population that is studied.
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
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Most studies investigating the relationship between activity
counts and activity intensity levels in adults, present cut-off points
for light, moderate and vigorous physical activity. It is important
to note that cut-offs validated in a specific age group might not
be valid for other age groups due to different physical activity pat-
terns. Also, in assessing physical intensity levels in patients with HF,
we believe that monitoring of sedentary time is important. There-
fore, we recommend to use cut-off points for adult patients with
HF that can calculate activity counts in sedentary physical activity
as moderate to vigorous physical activity (Table 3).44,45
Only a few have investigated cut-off points for older adults, such
as the typical HF population.45–48 When the study population are
the elderly HF patients (with possible multi-comorbid disorders
and frailty conditions), we recommend using cut-offs that are
advised for use in older adults (Table 3) due to different moving
patterns between these groups.
Consider data storage, data access
and completeness
Data storage is another important feature when choosing the right
activity monitor. An accurate measure of physical activity requires
at least 4 days of activity data, with a minimum use of 540 min/day.52
This determines the required battery longevity and the memory
capacity. However, if compliance is imperfect, an activity monitor
with a larger storage capacity (at least one week) and a battery
longevity that does not require frequent charging is recommended
for use. For example, the Fitbit Flex and the Fitbit Charge HR have
data storage of only 5 days and require frequent charging.
One aspect that is increasingly relevant to all research is the
ability to compare data across studies. This was also included in
a literature review23 looking at the methods used for collecting
physical activity data in patients with HF. Researchers and clinicians
are encouraged to improve the quality and transparency of data
collection and processing.
The key to success in this field, therefore, is that devices must
be able to provide raw activity data (activity counts) which can
then be translated into activity intensity levels. Uniaxial devices
provide raw activity counts in one plane only, usually vertical to
the ground, translated into number of steps. Since physical activity
is often more complex than simple steps, this might not be suffi-
cient for detailed assessment in clinical practice and is unlikely to be
useful for research purposes. The data from biaxial, triaxial or mul-
tisensory activity monitors are likely to provide a more complete
impression. However, we could not find any research on patients
with HF using biaxial activity monitors, and the TracmorD software
does not give the raw data in activity counts and activity intensity. It
is also unclear which cut-offs are programmed in the analysis soft-
ware to calculate the activity counts and to translate these into
activity intensity levels. The TracmorD, Fitbit Flex and Fitbit Charge
HR activity monitors are now only available as commercial devices.
As a consequence, the collected data are uploaded to a cloud-based
storage system, which patients and researchers do not own them-
selves. As a result, access to the activity counts could be challeng-




















































































Another consideration when choosing an activity monitor is costs,
which range between € 10 for a uniaxial monitor and € 2115 for
a multisensory monitor. One monitor could be rented for periods
of time.
Limitation and future directions
Unfortunately, it is often not possible to field validate activity
monitors due to the costs of doubly labelled water testing, the ‘gold
standard’. Because the doubly labelled water technique is based on
body’s metabolism, and this will not change due to HF, we believe
that devices that are field validated are also considered as validated
devices for patients with HF.
When it is not possible to field validate an activity monitor,
laboratory validation could be a solution. Unfortunately, we found
only laboratory validation in healthy adults, overweight adults or
stroke patients but no data around validation in patients with HF.
Future research should focus on either field validation of new
devices or laboratory validation of devices in patients with HF. Since
HF includes a wide variety of phenotypes, with widely differing left
ventricular ejection fraction and conditioning levels, an effort to be
able to analyse these distinctions with activity monitors, providing
a precise phenotype-driven cut-off point, should be pursued.
Pre-determined decisions about data collection (e.g. activity
monitor placement, wear time) and processing (e.g. non-wear-time
definition, cut-off points) in relation to the study participants and
the objective of the study are important when planning research in
this area.53
Physical activity is the prolongation of cardiac rehabilitation and
this was shown to reduce hospitalizations. However, no data exist
in a study using activity monitors that showed a reduction in
hospitalizations. In order to understand the relationship between
physical activity and (re)hospitalization, future research should
focus on monitoring patient their long-term physical activity to
detect possible deterioration. We also believe that future research
should explore the relation between physical activity and traditional
measures of functional status (e.g. New York Heart Association
class, 6-min walk test, cardiopulmonary exercise testing).
The development of activity monitors is evolving rapidly and
therefore we aim to update the data on available activity monitors
used in HF research regularly.
Conclusions
The choice of a monitor should depend on the research aims and
design regarding physical activity. If the aim is to motivate patients
to be active or set goals, a less rigorously tested tool can be con-
sidered, such as step counters or smartphone/watch applications.
On the other hand, if the aim is to measure physical activity and
its changes over time or with treatment, it is important to choose
a validated activity monitor (preferable with field validation) and
choose activity intensity cut-offs points that are appropriate for the
elderly co-morbid population commonly represented in HF. Fur-
thermore, the device needs to have a storage with battery longevity
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
90 L. Klompstra et al.
of at least one week to be able to compare to other research, and
must be able to provide raw data. Other considerations in choos-
ing an activity monitor should be where the data are stored, who
owns the collected physical activity data and the costs. This article
summarizes the practical and scientific differences between activity
monitors used in research on patients with HF, to help researchers
who study physical activity in patients with HF and who design and
evaluate interventions to choose the most appropriate monitor for
their requirements.
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